Breast cancer hypofractionated radiotherapy in 2-weeks with 2D technique: 5-year clinical outcomes of a phase 2 trial

BACKGROUND: To report clinical outcomes and late toxicities of a 2-week hypofractionated post-operative loco-regional radiotherapy in patients with breast cancer. MATERIALS AND METHODS: This trial was approved by the Institutional Ethics Committee and registered with gov, no. NCT02460744. Between Ju...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Budhi Singh, Dahiya, Divya, Gupta, Ankita, Rana, Diksha, Robert, Ngangom, Sharma, Manorma, Rao, Bharatbhushan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382075/
https://www.ncbi.nlm.nih.gov/pubmed/34434565
http://dx.doi.org/10.5603/RPOR.a2021.0054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382075/
https://www.ncbi.nlm.nih.gov/pubmed/34434565
http://dx.doi.org/10.5603/RPOR.a2021.0054

Ejemplares similares